Cargando…
Novel Drug Design for Treatment of COVID-19: A Systematic Review of Preclinical Studies
BACKGROUND: Since the beginning of the novel coronavirus (SARS-CoV-2) disease outbreak, there has been an increasing interest in discovering potential therapeutic agents for this disease. In this regard, we conducted a systematic review through an overview of drug development (in silico, in vitro, a...
Autores principales: | Mousavi, Sarah, Zare, Shima, Mirzaei, Mahmoud, Feizi, Awat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527439/ https://www.ncbi.nlm.nih.gov/pubmed/36199815 http://dx.doi.org/10.1155/2022/2044282 |
Ejemplares similares
-
The Isfahan Comprehensive Elderly Study: Objectives, research design, methodology, and preliminary results
por: Heidari, Zahra, et al.
Publicado: (2017) -
Incidence of nonmelanoma skin cancer in renal transplant recipients: A systematic review and meta-analysis
por: Matinfar, Mohammad, et al.
Publicado: (2018) -
Design and implementation of a combined observational and interventional study: Trends of prevalence, awareness, treatment and control hypertension and the effect of expanded chronic care model on control, treatment and self-care
por: Eghbali-Babadi, Maryam, et al.
Publicado: (2017) -
Computational drug design of novel COVID-19 inhibitor
por: Arthur, David Ebuka, et al.
Publicado: (2022) -
Vitamin D intake, serum Vitamin D levels, and risk of gastric cancer: A systematic review and meta-analysis
por: Khayatzadeh, Saeid, et al.
Publicado: (2015)